|
Volumn 20, Issue 4, 1998, Pages 450-451
|
Rifampin stability
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMYCOBACTERIAL AGENT;
RIFAMPICIN;
CLINICAL TRIAL;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG DETERMINATION;
DRUG MONITORING;
DRUG STABILITY;
FEMALE;
GOOD LABORATORY PRACTICE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
HUMAN EXPERIMENT;
LETTER;
MALE;
MYCOBACTERIOSIS;
NORMAL HUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
QUALITY CONTROL;
ADMINISTRATION, ORAL;
ANTIBIOTICS, ANTITUBERCULAR;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG MONITORING;
DRUG STABILITY;
FEMALE;
HUMANS;
MALE;
QUALITY CONTROL;
REFERENCE STANDARDS;
RIFAMPIN;
|
EID: 0031857043
PISSN: 01634356
EISSN: None
Source Type: Journal
DOI: 10.1097/00007691-199808000-00017 Document Type: Letter |
Times cited : (8)
|
References (3)
|